Does central obesity reflect 'Cushing's disease of the omentum '?

Lancet

Volumn 349, Issue 9060, 1997, Pages 1210-1213

  Bujalska, Iwona J ^a   Kumar, Sudhesh ^a   M Stewart, Paul ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; OXIDOREDUCTASE;

ABDOMINAL SURGERY; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; OBESITY; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION;

EID: 0030936556     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)11222-8     Document Type: Article

References (24)

1. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 14:1991;1132-1143.
2. Mayo-Smith W, Hayes CW, Biller BMK, Klibanski A, Rosenthal H, Rosenthal DI. Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa and patients with Cushing's syndrome. Radiology. 170:1989;515-518.
3. Rebuffe-Scrive M, Krotkiewski M, Elfersson J, Bjorntorp P. Muscle and adipose tissue morphology in Cushing's syndrome. J Clin Endocrinol Metab. 67:1988;1122-1125.
4. Hauner H, Entenmann G, Wabitsch M, et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest. 84:1989;1663-1670.
5. Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest. 92:1993;2191-2198.
6. Bronnegard M, Reynisdottir S, Marcus C, Stierna P, Arner P. Effect of glucocorticoid treatment on glucocorticoid receptor expression in human adipocytes. J Clin Endocrinol Metab. 80:1995;3608-3612.
7. Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity. Metabolism. 30:1981;89-104.
8. Stewart PM. 11ß-hydroxysteroid dehydrogenase - implications for clinical medicine. Clin Endocrinol (Oxf). 44:1996;493-499.
9. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11ß-hydroxysteroid dehydrogenase: structure, tissue distribution and chromosomal localization. J Biol Chem. 266:1991;16653-16658.
10. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11ß-hydroxysteroid dehydrogenase type 2 isoform. Mol Cell Endocrinol. 105:1994;R11-17.
11. Whorwood CB, Mason JI, Ricketts ML, Howie AJ, Stewart PM. Detection of human 11ß-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol Cell Endocrinol. 110:1995;R7-12.
12. Jamieson PM, Chapman KE, Edwards CRW, Seckl JR. 11ß-hydroxysteroid dehydrogenase is an exclusive 11ß-reductase in primary rat hepatocyte cultures: effect of physiochemical and hormonal manipulations. Endocrinology. 136:1995;4754-4761.
13. Edwards CRW, Stewart PM, Burt D, et al. Localisation of 11ß-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet. ii:1988;836-841.
14. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11ß-hydroxysteroid dehydrogenase. Nat Genet. 10:1995;394-399.
15. Stewart PM, Krozowski KS, Gupta A, et al. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the type 2 11ß-hydroxysteroid dehydrogenase gene. Lancet. 347:1996;88-91.
16. Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S, Mendelson C. Regulation of estrogen biosynthesis by human adipose cells. Endocr Rev. 10:1989;136-148.
17. Stewart PM, Murry BA, Mason JI. Human kidney 11ß-hydroxysteroid dehydrogenase is a high affinity NAD+-dependent enzyme and differs from the cloned type 1 isoform. J Clin Endocrinol Metab. 79:1994;480-484.
18. Bronnegard M, Arner P, Hellstrom L, Akner G, Gustafsson JA. Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue. Endocrinology. 127:1990;1689-1696.
19. Zhao Y, Mendelson CR, Simpson ER. Characterisation of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol Endocrinol. 9:1995;340-349.
20. Daromint C, Vassaux G, Ailhaud G, Negrel R. Differentiation of preadipose cells - paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology. 135:1994;2030-2036.
21. Dunkleman SS, Fairhurst B, Plager J, Waterhouse C. Cortisol metabolism in obesity. J Clin Endocrinol. 24:1964;832-841.
22. Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism. 41:1992;882-886.
23. Pasquali R, Cantobelli S, Casimirri F, et al. The hypothalamo-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 77:1993;341-346.
24. Edwards CRW, Stewart PM, Nairn IM, Grieve J, Shackelton CHL. Cushing's disease of the kidney. J Endocrinol. 104S:1985;53.